Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
110.4 USD | +1.08% |
|
+3.58% | +19.64% |
Jun. 25 | Blueprint Medicines Insider Sold Shares Worth $7,713,537, According to a Recent SEC Filing | MT |
Jun. 13 | CStone Gets Green Light for Local Manufacturing of AYVAKIT in China | MT |
Financials (USD)
Sales 2024 * | 432M | Sales 2025 * | 648M | Capitalization | 6.91B |
---|---|---|---|---|---|
Net income 2024 * | -152M | Net income 2025 * | -120M | EV / Sales 2024 * | 14.8 x |
Net cash position 2024 * | 514M | Net cash position 2025 * | 444M | EV / Sales 2025 * | 9.98 x |
P/E ratio 2024 * |
-47.2
x | P/E ratio 2025 * |
-79.7
x | Employees | 645 |
Yield 2024 * |
-
| Yield 2025 * |
0.91% | Free-Float | 99.08% |
Latest transcript on Blueprint Medicines Corporation
1 day | +1.08% | ||
1 week | +3.58% | ||
Current month | +2.39% | ||
1 month | +4.55% | ||
3 months | +20.53% | ||
6 months | +21.18% | ||
Current year | +19.64% |
![Extreme 103.015](/images/extremecours_fleche.png)
![Extreme 100.67](/images/extremecours_fleche.png)
![Extreme 72.24](/images/extremecours_fleche.png)
![Extreme 43.89](/images/extremecours_fleche.png)
![Extreme 37.82](/images/extremecours_fleche.png)
![Extreme 37.82](/images/extremecours_fleche.png)
![Extreme 13.04](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 16-01-04 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Director of Finance/CFO | 52 | 14-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lynn Seely
BRD | Director/Board Member | 65 | 16-04-13 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Lonnel Coats
BRD | Director/Board Member | 58 | 16-02-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.39% | 0 M€ | 0.00% | - | |
0.24% | 0 M€ | 0.00% | - | |
0.18% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 110.4 | +1.08% | 487,091 |
24-07-01 | 109.2 | +1.30% | 678,910 |
24-06-28 | 107.8 | -0.68% | 1,332,561 |
24-06-27 | 108.5 | +4.43% | 690,488 |
24-06-26 | 103.9 | -2.47% | 632,991 |
Delayed Quote Nasdaq, July 02, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.64% | 6.91B | |
+17.72% | 44.87B | |
-10.33% | 37.8B | |
+37.55% | 37.61B | |
+29.36% | 31.32B | |
-8.44% | 27.4B | |
+12.45% | 26.32B | |
+44.19% | 14.07B | |
+31.93% | 12.5B | |
-7.67% | 11.23B |
- Stock Market
- Equities
- BPMC Stock